ArticleHealth services research2026
Predictors of Colorectal Cancer Screening Rates in Federally Qualified Health Centers: Explicating Organizational Level Factors.
Article in Health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predictors of Colorectal Cancer Screening Rates in Federally Qualified Health Centers: Explicating Organizational Level Factors.Health services research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectiveTo examine changes in colorectal cancer (CRC) screening rates over time and determine organizational-level factors influencing these shifts. STUDY SETTIGN AND
designThis longitudinal study used mixed effects models to analyze data from Federally Qualified Health Centers (FQHCs) in the United States (US). Key organizational-level factors included Patient-Centered Medical Home (PCMH) recognition and duration, hypertension and diabetes management, and center-level characteristics such as racial composition, location, and center volume/size. DATA SOURCES AND ANALYTIC SAMPLE: This study used Uniform Data System (UDS) data from 2017 to 2022 for US-based FQHCs receiving full Public Health Service Section 330 grants and reporting CRC screening measures, excluding school-based centers, US territories, and look-alike centers. PRINCIPAL
findingsAmong the 1282 FQHCs analyzed, CRC screening rates were increasing before the COVID-19 pandemic but declined during and remain below pre-pandemic levels. FQHCs with consistent PCMH recognition reported significantly higher screening rates (β = 8.50, p < 0.001). Screening rates were also positively associated with a higher rate of controlled hypertension (β = 0.354, p < 0.0001) but lower in FQHCs with larger Black patient populations, Southern locations, and smaller center volume/size.
conclusionsConsistent PCMH recognition and chronic disease management are essential for improving CRC screening rates in FQHCs. By integrating these population health management strategies, FQHCs can proactively address screening disparities. Prioritizing these organizational-level approaches may strengthen healthcare equity and expand CRC screening for historically marginalized communities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.